Illegal Nicotine & E-cigarette Products Seized in Joint Action

Sep.08.2022
A joint operation by the police and trading standards seized illegal nicotine and e-cigarette products worth over £5,000.

A joint operation conducted by the police and the Trade Standards department led to the seizure of illegal nicotine and vaping products worth over £5,000 from a shop.


Due to reports of anti-social behavior (ASB), noise disturbance, drug dealing, and a large amount of intimidating group gatherings outside, Tower Hamlets Council has received complaints from residents about Cloudz Vapez, located on Roman Road. The report states that this shop sells illegal products at the counter, such as trademark and counterfeit e-cigarettes, as well as e-cigarettes that violate current legal nicotine restrictions.


The Trade Standards and Metropolitan Police conducted a raid on the premises, seizing 320 illegal nicotine and e-cigarette related products with an estimated value of over £5,000. Initially, the shop owner refused to provide his details to the police, but they were able to track him down through the Metropolitan database. The shop owner has received a warning from the Trade Standards and will now undergo a thorough investigation.


Chief member of Environment and Climate, and member of parliament Kabir Hussain stated:


Shops selling fake electronic cigarettes are facing real danger because they may contain harmful substances mixed with nicotine. Some e-cigarettes being sold also contain nicotine levels higher than what is allowed in the UK, posing a danger to users. The low prices of e-cigarettes have attracted young people and encouraged them to develop habits that can have lifelong effects on their health and well-being. During the raid, members of the public approached police officers to express their gratitude for their positive work. The operation is expected to send a strong message to shop owners and others selling illegal products and encourage ASB to show zero tolerance for this situation in our wards. This is a typical example of the importance of understanding local issues and the power of partnerships.


This article was compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not reflect the viewpoint of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of the content of the article. The compilation of this article is only intended for industry research and communication.


Due to limitations in our translation abilities, the translated article may not fully convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS aligns completely with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related views and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
York Traders Could Face Fines of Up to GBP 200 Under New Illegal Vape Enforcement Plans
York Traders Could Face Fines of Up to GBP 200 Under New Illegal Vape Enforcement Plans
City of York Council is considering new plans that would allow fines of up to GBP 200.00 (approximately USD 260.00) for traders caught selling illegal single-use vapes.
Apr.09 by 2FIRSTS.ai
Kyrgyzstan Plans to Extend E-Cigarette Import Ban by Another Six Months
Kyrgyzstan Plans to Extend E-Cigarette Import Ban by Another Six Months
According to Kyrgyzstan’s Ministry of Economy, the government plans to extend the current ban on e-cigarette imports by another six months once the existing measure expires, with the new restriction set to take effect on July 10, 2026. The ban covers disposable e-cigarettes as well as nicotine-containing liquids for reusable systems.
Apr.17 by 2FIRSTS.ai
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G Approves Plan to Establish Guatemala Branch as First Local Base in Central and South America
KT&G has approved a plan to establish a branch in Guatemala, which will serve as its first local base in Central and South America. The company is currently preparing office space, staffing, and operating systems. KT&G said the branch is intended to secure a regional distribution base and will focus on local channel management and new sales channel expansion. Meanwhile, overseas cigarette revenue in 2025 exceeded the domestic share for the first time.
Mar.09 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02